Literature DB >> 11855743

Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.

M Hermes-Lima1, M S Gonçalves, R G Andrade.   

Abstract

Pyridoxal isonicotinoyl hydrazone (PIH) is an iron chelator with antioxidant activity, low toxicity and is useful in the experimental treatment of iron-overload diseases. Previous studies on x-ray diffraction have revealed that PIH also forms a complex with Cu(II). Since the main drug of choice for the treatment of Wilson's disease, d-penicillamine, causes a series of side effects, there is an urgent need for the development of alternative copper chelating agents for clinical use. These chelators must also have antioxidant activity because oxidative stress is associated with brain and liver copper-overload. In this work we tested the ability of PIH to prevent in vitro free radical formation mediated by Cu(II), ascorbate and dissolved O2. Degradation of 2-deoxyribose mediated by 10 microM Cu(II) and 3 mM ascorbate was fully inhibited by 10 microM PIH (I50 = 6 microM) or 20 microM d-penicillamine (I50 = 10 microM). The antioxidant efficiency of PIH remained unchanged with increasing concentrations (from 1 to 15 mM) of the hydroxyl radical detector molecule, 2-deoxyribose, indicating that PIH does not act as a hydroxyl scavenger. On the other hand, the efficiency of PIH (against copper-mediated 2-deoxyribose degradation and ascorbate oxidation) was inversely proportional to the Cu(II) concentration, suggesting a competition between PIH and ascorbate for complexation with Cu(lI). An almost full inhibitory effect by PIH was observed when the ratio PIH:copper was 1:1. A similar result was obtained with the measurement of copper plus ascorbate-mediated O2 uptake. Moreover, spectral studies of the copper and PIH interaction showed a peak at 455 nm and also indicated the formation of a stable Cu(II) complex with PIH with a 1:1 ratio. These data demonstrated that PIH prevents hydroxyl radical formation and oxidative damage to 2-deoxyribose by forming a complex with Cu(II) that is not reactive with ascorbate (first step of the reactions leading to hydroxyl radical formation from Cu(II), ascorbate and O2) and does not participate in Haber-Weiss reactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11855743     DOI: 10.1023/a:1013348005312

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  42 in total

1.  In vitro antioxidant properties of the iron chelator pyridoxal isonicotinoyl hydrazone and some of its analogs.

Authors:  H M Schulman; M Hermes-Lima; E M Wang; P Ponka
Journal:  Redox Rep       Date:  1995-11       Impact factor: 4.412

2.  Copper in plasma reflects its status and subsequent toxicity in the liver of LEC rats.

Authors:  M Rui; K T Suzuki
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1997-12

3.  Localization of the Wilson's disease protein in human liver.

Authors:  M Schaefer; H Roelofsen; H Wolters; W J Hofmann; M Müller; F Kuipers; W Stremmel; R J Vonk
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

4.  D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation.

Authors:  G Starkebaum; R K Root
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

5.  Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.

Authors:  C C Huang; N S Chu
Journal:  Eur Neurol       Date:  1998       Impact factor: 1.710

6.  Prevention of postasphyxia electroretinal dysfunction with a pyridoxal hydrazone.

Authors:  M Bhattacharya; P Ponka; P Hardy; N Hanna; D R Varma; P Lachapelle; S Chemtob
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

7.  Copper(I) and copper(II) in complexes of biochemical significance studied by X-ray photoelectron spectroscopy.

Authors:  H Rupp; U Weser
Journal:  Biochim Biophys Acta       Date:  1976-09-28

8.  Effects of an inhibitor and a mimic of superoxide dismutase on bleomycin mutagenesis in Chinese hamster ovary cells.

Authors:  J An; A W Hsie
Journal:  Mutat Res       Date:  1992-11-16       Impact factor: 2.433

9.  On the reaction of molecular oxygen with thiyl radicals: a re-examination.

Authors:  J Mönig; K D Asmus; L G Forni; R L Willson
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1987-10

10.  Penicillamine-induced rapidly progressive glomerulonephritis in patients with progressive systemic sclerosis: successful treatment of two patients and a review of the literature.

Authors:  K A Ntoso; J E Tomaszewski; S A Jimenez; E G Neilson
Journal:  Am J Kidney Dis       Date:  1986-09       Impact factor: 8.860

View more
  1 in total

1.  Antioxidant Activity of Caffeic Acid against Iron-Induced Free Radical Generation--A Chemical Approach.

Authors:  Thiago C Genaro-Mattos; Ângelo Q Maurício; Daniel Rettori; Antonio Alonso; Marcelo Hermes-Lima
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.